Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised,double-blind, phase 3a trial
Sharon said, noting that there isnt any definitive evidence yet on this question one way or the other. Answering such questions could take years, but efforts are under way to advance the research
At a physician-led clinic in Phuket, these protocols are not selected from a menu they are prescribed following a comprehensive clinical assessment of your health history, goals and laboratory markers
Phung OJ, Sobieraj DM, Engel SS, Rajpathak SN
Fact : Actually, these drugs are very safe as proven by extensive clinical testing
An additional 14% feel the risk is serious enough that it should affect eligibility or duration of treatment